ETF Managers Group’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$213K Buy
+8,890
New +$159K 0.01% 577
2022
Q4
Sell
-7,843
Closed -$116K 529
2022
Q3
$116K Sell
7,843
-504
-6% -$8.46K ﹤0.01% 643
2022
Q2
$129K Buy
8,347
+347
+4% +$6.81K ﹤0.01% 673
2022
Q1
$220K Buy
8,000
+31
+0.4% +$791 ﹤0.01% 597
2021
Q4
$310K Sell
7,969
-1,150
-13% -$46.9K 0.01% 591
2021
Q3
$426K Buy
9,119
+1,356
+17% +$60.8K 0.01% 562
2021
Q2
$268K Sell
7,763
-10,058
-56% -$340K ﹤0.01% 592
2021
Q1
$691K Buy
17,821
+5,908
+50% +$352K 0.01% 334
2020
Q4
$556K Sell
11,913
-1,755
-13% -$119K 0.01% 322
2020
Q3
$584K Buy
13,668
+7,008
+105% +$348K 0.02% 278
2020
Q2
$313K Buy
+6,660
New +$230K 0.01% 392

Other funds holding ARCT